We are live on ! Find out more
Invesco

Invesco Portfolio holdings

AUM $1.02T
1-Year Est. Return 30.18%
 

Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.

This Fund
S&P 500
This Quarter Est. Return
+20.62%
1 Year Est. Return
+30.18%
3 Year Est. Return
+96.06%
5 Year Est. Return
+126.45%
10 Year Est. Return
+482.58%
AUM
$344B
AUM Growth
+$47.8B
Cap. Flow
-$1.28B
Cap. Flow %
-0.37%
Top 10 Hldgs %
12.06%
Holding
3,896
New
276
Increased
1,854
Reduced
1,496
Closed
132

Top Buys

Rank Stock Value
1
PDD icon
Pinduoduo
PDD
+$707M
2
DIS icon
Walt Disney
DIS
+$452M
3
AVB icon
AvalonBay Communities
AVB
+$351M
4
LLY icon
Eli Lilly
LLY
+$285M
5
AAPL icon
Apple
AAPL
+$283M

Sector Composition

Rank Sector Weight
1 Technology 19.95%
2 Consumer Discretionary 13.11%
3 Healthcare 12.92%
4 Financials 12.43%
5 Industrials 9.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AKBA icon
3576
Akebia Therapeutics
AKBA
$338M
$83K ﹤0.01%
29,697
-576,649
-95% -$1.68M
QTNT
3577
DELISTED
Quotient Limited Ordinary Shares
QTNT
$83K ﹤0.01%
+398
New +$92.7K
XCUR icon
3578
Exicure
XCUR
$11M
$82K ﹤0.01%
+309
New +$77.3K
BIOR
3579
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$82K ﹤0.01%
+62
New +$90.9K
RESN
3580
DELISTED
Resonant Inc.
RESN
$82K ﹤0.01%
+30,773
New +$72.7K
SFE
3581
DELISTED
Safeguard Scientifics, Inc.
SFE
$81K ﹤0.01%
12,716
-7,883
-38% -$49.2K
BDSI
3582
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$81K ﹤0.01%
+19,168
New +$73.9K
ASMB icon
3583
Assembly Biosciences
ASMB
$498M
$80K ﹤0.01%
+1,104
New +$130K
CLVS
3584
DELISTED
Clovis Oncology, Inc.
CLVS
$80K ﹤0.01%
+16,704
New +$84.5K
WNEB icon
3585
Western New England Bancorp
WNEB
$260M
$79K ﹤0.01%
+11,551
New +$75.1K
HALL
3586
DELISTED
Hallmark Financial Services, Inc.
HALL
$79K ﹤0.01%
2,217
-96
-4% -$3K
MBIO icon
3587
Mustang Bio
MBIO
$4.39M
$77K ﹤0.01%
+27
New +$64.5K
VNRX icon
3588
VolitionRx Ltd
VNRX
$9.31M
$77K ﹤0.01%
+987
New +$68K
NH
3589
DELISTED
NantHealth, Inc
NH
$77K ﹤0.01%
+1,588
New +$59.7K
GNSS icon
3590
Genasys
GNSS
$76.5M
$76K ﹤0.01%
+11,738
New +$75.8K
UTI icon
3591
Universal Technical Institute
UTI
$2.26B
$76K ﹤0.01%
+11,693
New +$67K
PTRS
3592
DELISTED
Partners Bancorp Common Stock
PTRS
$76K ﹤0.01%
+11,593
New +$67.5K
ELA icon
3593
Envela
ELA
$551M
$75K ﹤0.01%
+14,515
New +$64.6K
FENC icon
3594
Fennec Pharmaceuticals
FENC
$335M
$75K ﹤0.01%
+10,133
New +$77.2K
GYRE icon
3595
Gyre Therapeutics
GYRE
$629M
$75K ﹤0.01%
+1,594
New +$69K
MLSS icon
3596
Milestone Scientific
MLSS
$33.3M
$75K ﹤0.01%
+35,183
New +$61.9K
RNAC icon
3597
Cartesian Therapeutics
RNAC
$218M
$75K ﹤0.01%
+824
New +$71.5K
IMDX
3598
Insight Molecular Diagnostics
IMDX
$141M
$74K ﹤0.01%
+1,556
New +$57.1K
TREC
3599
DELISTED
Trecora Resources
TREC
$74K ﹤0.01%
+10,509
New +$70.6K
TGS icon
3600
Transportadora de Gas del Sur
TGS
$4.48B
$73K ﹤0.01%
14,032
-15,894
-53% -$82.2K

Similar funds

Invesco's Q4 2020 Portfolio in Review

As of Q4 2020, Invesco held 3,896 positions worth $344B, up 16% from $296B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Invesco's Q4 2020 filing shows 276 new, 1,854 increased, 1,496 reduced and 132 closed positions. Its largest new stake was Array Technologies: 3,528,447 shares worth $152M. The largest sale was Alibaba, an estimated $932M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Invesco's largest Q4 2020 buy was Array Technologies: 3,528,447 shares worth $152M.
  • Invesco added most to Pinduoduo in Q4 2020, an estimated $707M increase.
  • Invesco's biggest Q4 2020 reduction was Alibaba, cutting an estimated $932M.
  • Invesco fully exited MyoKardia, Inc. Common Stock in Q4 2020, selling an estimated $176M.
  • Invesco's ten largest holdings make up 12% of its $344B portfolio in Q4 2020.
  • Invesco opened 276 new positions and closed 132 in Q4 2020.
  • Invesco's portfolio value rose 16% quarter-over-quarter to $344B.

Based on Invesco's 13F filing for Q4 2020, filed 16 Feb 2021.